Senate asks health minister to get emergency Ebola vaccines

Leslie Hanson
May 16, 2018

Samples from two suspect cases in the Wangata health zone in Mbandaka are being analyzed, the ministry said in a statement emailed from the capital, Kinshasa, late Monday.

Moving the motion on the floor of the senate on Tuesday, Tinubu cited a report that of the World Health Organisation (WHO) which said "Nigeria and other African countries are at modest risk of spread".

The incubation period of the virus ranges from two to 21 days, and people become infectious after the onset of symptoms, he said, adding that early symptoms include sudden onset of fever, intense weakness, muscle pain, headache and sore throat, followed by vomiting, diarrhea, abdominal pain, rashes and internal and external bleeding in some cases.

"We have agreement, registration, plus import permit — everything formally agreed already".

Information about the outbreak in Bikoro, Iboko and Wangata in Equateur province was still limited, the WHO said, but at present the outbreak does not meet the criteria for declaring a "public health event of global concern", which would trigger the formation of an emergency WHO committee.


It further urged the Minister of Health to ensure alertness to combat whatever cases thst might arise and get Ebola vaccines ready for an emergency.

The Ebola-hit Bikoro, Iboko, and Wangata health zones are located in the Equateur province.

The WHO has a stockpile of 4,300 doses of the vaccine in Geneva; the company also has 300,000 doses of the vaccine stockpiled in the United States.

This is the DRC's ninth EVD outbreak since the virus was discovered in the country in 1976.

The new experimental vaccine, developed by the Canadian government and now licensed to the USA -based Merck and has been shown to be highly effective against the virus. It was tested in West - Africa in 2015 during an Ebola epidemic that killed more than 11,300 people in Guinea, Sierra Leone and Liberia.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER